Return
Editor’s pick: Excelsior Sciences
C
DOI:10.1038/s41587-026-03249-3.png)
Abstract
En 中文
Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Excelsior Sciences is developing a closed-loop system for drug discovery using carbon building bloccs.
Journal
IF:
41.7
Papers:
1.2W
Citations:
10.1W
Organization
No organization information available
